BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 2038173)

  • 1. Pharmacodynamic and kinetic considerations on diuretics as a basis for differential therapy.
    Knauf H; Mutschler E
    Klin Wochenschr; 1991 Apr; 69(6):239-50. PubMed ID: 2038173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose segmental blockade of the nephron rather than high-dose diuretic monotherapy.
    Knauf H; Mutschler E
    Eur J Clin Pharmacol; 1993; 44 Suppl 1():S63-8. PubMed ID: 8486149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mechanism of action of xipamide and its classification as a "low ceiling diuretic". Pharmacodynamic-pharmacokinetic studies in healthy volunteers and in kidney and liver patients].
    Knauf H; Mutschler E
    Arzneimittelforschung; 2005; 55(1):1-14. PubMed ID: 15727159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coadministration of thiazides increases the efficacy of loop diuretics even in patients with advanced renal failure.
    Fliser D; Schröter M; Neubeck M; Ritz E
    Kidney Int; 1994 Aug; 46(2):482-8. PubMed ID: 7967362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiazides and loop-diuretics therapeutic aspects.
    Beermann B
    Acta Med Scand Suppl; 1986; 707():75-8. PubMed ID: 3461688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diuretics. Clinical pharmacology and therapeutic use (Part I).
    Lant A
    Drugs; 1985 Jan; 29(1):57-87. PubMed ID: 3882391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of cardiovascular and antiinflammatory drugs on thiazide-induced hemodynamic and saluretic effects.
    Knauf H; Bailey MA; Hasenfuss G; Mutschler E
    Eur J Clin Pharmacol; 2006 Nov; 62(11):885-92. PubMed ID: 16964522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Action of diuretics at the cellular level.
    Greger R; Lohrmann E; Schlatter E
    Clin Nephrol; 1992; 38 Suppl 1():S64-8. PubMed ID: 1338305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential nephron blockade breaks resistance to diuretics in edematous states.
    Knauf H; Mutschler E
    J Cardiovasc Pharmacol; 1997 Mar; 29(3):367-72. PubMed ID: 9125675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The loop diuretic torasemide in chronic renal failure. Pharmacokinetics and pharmacodynamics.
    Knauf H; Spahn H; Mutschler E
    Drugs; 1991; 41 Suppl 3():23-34. PubMed ID: 1712713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Saluretic effect of the loop diuretic torasemide in chronic renal failure. Interdependence of electrolyte excretion.
    Knauf H; Mutschler E
    Eur J Clin Pharmacol; 1990; 39(4):337-43. PubMed ID: 2076714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Renal function, organic acid transport and protein binding: the three elements defining the response to diuretics in clinical practice: an update].
    Conz PA
    G Ital Nefrol; 2005; 22(3):209-16. PubMed ID: 16001364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative mechanisms of action of diuretic drugs in hypertension.
    van Zwieten PA
    Eur Heart J; 1992 Dec; 13 Suppl G():2-4. PubMed ID: 1486901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Site and mechanism of the action of diuretics.
    Odlind B
    Acta Pharmacol Toxicol (Copenh); 1984; 54 Suppl 1():5-15. PubMed ID: 6369884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Torasemide significantly reduces thiazide-induced potassium and magnesium loss despite supra-additive natriuresis.
    Knauf H; Mutschler E; Velazquez H; Giebisch G
    Eur J Clin Pharmacol; 2009 May; 65(5):465-72. PubMed ID: 19229529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights into diuretic use in patients with chronic renal disease.
    Wilcox CS
    J Am Soc Nephrol; 2002 Mar; 13(3):798-805. PubMed ID: 11856788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnesium and potassium-sparing diuretics.
    Ryan MP
    Magnesium; 1986; 5(5-6):282-92. PubMed ID: 3543514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A micropuncture study on the renal site of action of ICI 206,970, a unique eukalemic diuretic.
    Johnston PA; Kau ST
    J Pharmacol Exp Ther; 1993 Feb; 264(2):604-8. PubMed ID: 8437111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamics and pharmacokinetics of xipamide in patients with normal and impaired kidney function.
    Knauf H; Mutschler E
    Eur J Clin Pharmacol; 1984; 26(4):513-20. PubMed ID: 6734710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.